SORL1 and Alzheimer disease: Potentially damaging SORL1 variants affect as many as 2.75% of all genetically unrelated early onset AD cases (EOAD, with Age at Onset (AAO) < 65 years) and 1.5% of genetically unrelated late onset AD cases (LOAD, with AAO > 65 years) [13].